Stock Under $10 with 50-100% upside potential - 14 Days FREE!

5 Biotech Stocks Under $5 Making Bullish Moves

Stock quotes in this article: MNKD, CBLI, BMTI, ANTH, CYTX 

BioMimetic Therapeutics

Content on this page requires a newer version of Adobe Flash Player.

Get Adobe Flash player

BioMimetic Therapeutics (BMTI) is a biotechnology company. The company develops and commercializes products to promote the healing of musculoskeletal injuries and diseases, including orthopedic, sports medicine and spine applications. This stock is trading up 8.8% at $2.94 in recent trading.

Today's Range: $2.65-$3.15

52-Week Range: $1.87-$5.59

Volume: 242,000

Three-Month Average Volume: 151,214

>>5 Stocks Under $10 Set to Soar

From a technical perspective, BMTI is skyrocketing here back above its 200-day moving average of $2.66 with heavy volume. This move has now triggered a near-term breakout trade above $2.69 to $2.78, and this stock is flirting with an even bigger breakout trade. That bigger trade will hit once BMTI takes out some past overhead resistance at $3.01 to $3.20 with high-volume. At last check, shares of BMTI have hit an intraday high of $3.15, but it has since pulled back to its current price just under $3.

Traders should now look for long-biased trades if BMTI can sustain a move or close above $3.01 to $3.20 with volume that's near or above 151,214 shares. If we get that action today or soon, look for BMTI to re-test and possibly take out its next significant overhead resistance levels at $3.75 to $4.20.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
TRY IT FREE

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Dividend Stock Advisor
TRY IT FREE
New! $49.95/yr

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREE

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Real Money
TRY IT FREE

24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.

Product Features:
  • Jim Cramer + 20 Wall Street pros
  • Intraday commentary & news
  • Real-time trading forum
  • Actionable trade ideas
Real Money Pro
TRY IT FREE

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass + 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
TRY IT FREE

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
DOW 15,294.50 -12.67 -0.08%
NASDAQ 3,459.42 -3.88 -0.11%
S&P 500 1,650.51 -4.84 -0.29%
US 10 Yr 2.023% -0.003

Brokerage Partners

Advertising Partners
Special Features

Free Newsletters from TheStreet

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

We respect your privacy. Manage Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs